The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis

Keyphrases

• Mitochondria 100%
• Tumorigenesis 100%
• Mitochondrial Accumulation 100%
• Genomic Landscape 100%
• Oncocytoma 100%
• Chromophobe Renal Cell Carcinoma (chRCC) 100%
• Metabolic Checkpoint 100%
• Renal Oncocytoma 100%
• Metabolic Barrier 100%
• High Risk 50%
• TP53 mutation 50%
• Exome Sequencing 50%
• Autophagosome 50%
• Metformin 50%
• Golgi 50%
• Tumor Progression 50%
• Chromosome 1 50%
• Transcriptome Sequencing 50%
• Mitochondrial Inhibitors 50%
• Genetic Defects 50%
• Respiration 50%
• Alleviation 50%
• Mitochondrial Function 50%
• Tumor Protein p53 (TP53) 50%
• Cyclin D1 (CCND1) 50%
• Tumor Suppression 50%
• Benign Neoplasm 50%
• Chromosome X 50%
• Chromosome Y 50%
• Autophagy Dysfunction 50%
• Uncertain Significance 50%
• Suppression Mechanism 50%
• Mitochondrial mutations 50%
• Lysosome Trafficking 50%
• 5′-adenosine Monophosphate-activated Protein Kinase 50%

Medicine and Dentistry

• Protein P53 100%
• Carcinogenesis 100%
• Renal Oncocytoma 100%
• Clear Cell Renal Cell Carcinoma 66%
• Mitochondrion 66%
• Eosinophilic 66%
• Autophagy 66%
• Oncocytoma 66%
• Neoplasm 33%
• RNA Sequencing 33%
• Benign Tumor 33%
• Genetic Disorder 33%
• X Chromosome 33%
• Lysosome 33%
• Adenosine Phosphate 33%
• Glycon 33%
• Tumor Progression 33%
• Aneuploidy 33%
• Y Chromosome 33%
• Exome Sequencing 33%
• Protein Kinases 33%
• Chromosome 1 33%

Biochemistry, Genetics and Molecular Biology

• Carcinogenesis 100%
• P53 100%
• Genomics 100%
• Mitochondrion 66%
• Autophagy 66%
• X Chromosome 33%
• Genetics 33%
• Tumor Progression 33%
• Protein Kinases 33%
• Lysosome 33%
• Y Chromosome 33%
• Adenosine Monophosphate 33%
• RNA Sequencing 33%
• Chromosome 1 33%
• Exome Sequencing 33%